Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon
arrow-right
Use Icons In The App

Try a synonym, or sign up to request an icon from the app.

TGF beta (type I, short)

TGF beta (type I, short) - Editable icon of a short TGF beta type 1 receptor with a ligand binding site and intracellular serine/threonine kinase domain
[{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a36/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a36/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a35/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a35/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a34/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a34/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a33/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a33/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a32/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a32/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a31/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a31/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a30/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a30/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2f/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2f/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2e/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2e/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2d/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2d/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2c/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2c/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2b/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2b/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a2a/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a2a/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a29/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a29/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a28/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a28/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a27/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a27/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a26/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a26/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a25/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a25/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a24/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a24/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a23/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a23/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a22/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a22/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a21/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a21/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a20/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a20/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1f/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1f/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1e/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1e/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1d/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1d/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1c/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1c/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1b/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1b/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a1a/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a1a/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a19/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a19/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a18/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a18/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a17/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a17/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a16/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a16/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a15/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a15/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a14/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a14/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a13/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a13/63331d69d8c4400021f6fa7c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333325ef544890021309a12/63331d69d8c4400021f6fa7c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333325ef544890021309a12/63331d69d8c4400021f6fa7c.png"}]
Keywords
TGF beta,transforming growth factor beta,serine kinase receptor,TGF β,TGF,beta,threonine kinase receptor,kinase receptor,type I,type II,type 1,type 2,serine,threonine,kinase,short,proj-shortreceptor-icons-22q1,TGF
Image types

TGF beta (type I, short) icon JPEG

TGF beta (type I, short) icon PNG

TGF beta (type I, short) icon SVG

TGF beta (type I, short) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this TGF beta (type I, short) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the TGF beta (type I, short) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the TGF beta (type I, short) icon customizable in BioRender?
Most icons in BioRender, including the TGF beta (type I, short) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the TGF beta (type I, short) icon in their work?
BioRender users often use the TGF beta (type I, short) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.
Can I export figures that include the TGF beta (type I, short) icon for publication or presentations?
Yes, figures containing the TGF beta (type I, short) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the TGF beta (type I, short) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the TGF beta (type I, short) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now